Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

Immunotherapy in thoracic malignancies: What has been achieved in 2019?

Does radiotherapy still have a role in stage III NSCLC in the era of immunotherapy? The radiotherapist’s view

Date

29 Sep 2019

Session

Immunotherapy in thoracic malignancies: What has been achieved in 2019?

Topics

Management of Systemic Therapy Toxicities;  Tumour Immunology;  Immunotherapy;  Supportive Care and Symptom Management;  Radiation Oncology

Tumour Site

Presenters

Kevin Franks

Authors

K. Franks

Author affiliations

  • /US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.